Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mucosal immune cell membrane is the specialized lipid bilayer and protein complex of immune cells located in the mucosa-associated lymphoid tissue (MALT), including the gut, respiratory, and urogenital tracts (Nature Reviews Immunology, 2003). It serves as the primary interface for immune surveillance, facilitating the recognition of antigens and the regulation of local inflammatory responses (Journal of Clinical Investigation, 2014). This membrane is characterized by the expression of unique homing receptors, such as the alpha-4 beta-7 integrin and CCR9, which are essential for the site-specific migration of lymphocytes to mucosal tissues (New England Journal of Medicine, 2013). In autoimmune and inflammatory diseases like Crohn's disease and ulcerative colitis, the dysregulation of these membrane proteins leads to the pathological accumulation of inflammatory cells. Therapeutic agents, such as Vedolizumab, target specific proteins on this membrane to selectively inhibit leukocyte trafficking to the gut, thereby reducing inflammation while minimizing systemic immunosuppression (Gastroenterology, 2014). Understanding the molecular landscape of the mucosal immune cell membrane is vital for developing targeted therapies that maintain mucosal barrier integrity and treat chronic inflammatory conditions.
Drugs targeting this site typically function as antagonists of membrane-bound adhesion molecules or chemokine receptors, thereby preventing the recruitment of pathogenic leukocytes into mucosal tissues (Nature Reviews Drug Discovery, 2018).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucosal immune cell membrane.